1. The use of the salt of bicyclo [2.2.2] octane-2-carboxylate for the treatment of dysphoria in a subject. Use of a bicyclo [2.2.2] octane-2-carboxylate salt for treating alcohol dependence in a subject. 3. Use of a bicyclo [2.2.2] octane-2-carboxylate salt for treating liver dysfunction characterized by abnormal levels of ACT (aspartate aminotransferase), ALT (alanine aminotransferase), or bilirubin in a subject. 4. Use of a bicyclo [2.2.2] octane-2-carboxylate salt for treating a disease associated with an increased erythrocyte sedimentation rate in a subject. 5. Use of a bicyclo [2.2.2] octane-2-carboxylate salt to reduce the number or seizure power of a human subject suffering from epilepsy. 6. The use according to any one of claims 1 to 5, wherein at least 400 mg per day of the bicyclo [2.2.2] octane-2-carboxylate salt is administered. The use according to claim 1 or 5, wherein the subject is treated with at least one anticonvulsant drug selected from the group consisting of Depakine, Carbamazepine, Lamiktal, Benzonal, Finlepsin, Clonazepam, Pagluferal, Finlepsin Retard, Hexamidine, Tegretol, Topamax, Difenin Glycine and Biotredin. 8. The use according to any one of claims 1 to 4, wherein the subject suffers from epilepsy. The use according to any one of claims 1 to 5, wherein the bicyclo [2.2.2] octane-2-carboxylate salt is administered to the subject for at least 60 days. The use according to any one of claims 1 to 5, wherein the bicyclo [2.2.2] octane-2-carboxylate salt is administered orally to the subject.1. Применение соли бицикло[2.2.2]октан-2-карбоксилата для лечения дисфории у субъекта.2. Применение соли бицикло[2.2.2]октан-2-карбоксилата для лечения алкогольной зависимости у субъекта.3. Применение соли бицикло[2.2.2]октан-2-карбоксилата для лечения дисфункции печени, характеризующейся аномальными уровнями ACT (аспартатаминотрансфераза), АЛТ (аланинаминотрансфераза) или билирубина, у субъекта.4. Применение соли бицикло[2.2.2]октан-2-карбоксилата для л
